Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma

Published:2019 Issue:42 Volume:9 Page:24471-24482
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Cui Jiajia¹²³⁴⁵,Zheng Xiwang¹²³⁴⁵,Yang Dongli¹²³⁴⁶,Hu Yinghuan¹²³⁴⁵,An Changming⁷⁸⁹¹⁰¹¹,Bo Yunfeng¹²¹³¹⁴³⁴,Li Huizheng⁶¹⁵¹⁶⁴,Zhang Yuliang¹²³⁴⁵,Niu Min¹²³⁴⁵,Xue Xuting¹²³⁴⁵,Lu Yan⁶¹⁷¹⁸¹⁹⁴,Tang Yemei¹²³⁴⁶,Yin Hongyu¹²³⁴⁶,Li Zhenyu²⁰²¹³⁴⁵^ORCID,Gao Wei¹²³⁴⁶^ORCID,Wu Yongyan¹²³⁴⁶^ORCID

Affiliation:

1. Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer

2. First Hospital of Shanxi Medical University

3. Taiyuan 030001

4. China

5. The Key Scientific and Technological Innovation Platform for Precision Diagnosis and Treatment of Head and Neck Cancer

6. Department of Otolaryngology Head & Neck Surgery

7. Department of Head and Neck Surgery

8. Cancer Hospital

9. National Cancer Center

10. Chinese Academy of Medical Sciences

11. Peking Union Medical College

12. Department of Pathology

13. Shanxi Cancer Hospital

14. Shanxi Medical University

15. Dalian Municipal Friendship Hospital

16. Dalian 116001

17. The First Hospital

18. Jinzhou Medical University

19. Jinzhou 121001

20. Modern Research Center for Traditional Chinese Medicine

21. Shanxi University

Abstract

Astragali radix total flavonoid synergizes with cisplatin to inhibit tumorigenesis of laryngeal squamous cell carcinoma.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Shanxi Scholarship Council of China

Shanxi Medical University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/RA/C9RA04701H

Reference44 articles.

1. An update on larynx cancer

2. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1

3. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma

4. Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer

5. Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ononin: A comprehensive review of anticancer potential of natural isoflavone glycoside;Journal of Biochemical and Molecular Toxicology;2024-05-21

2. M6A reader YTHDF1 promotes malignant progression of laryngeal squamous carcinoma through activating the EMT pathway by EIF4A3;Cellular Signalling;2024-02

3. Unveiling the potential anti‐cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research;Cancer Medicine;2024-01-17

4. Antitumor Effects of Ononin by Modulation of Apoptosis in Non-Small-Cell Lung Cancer through Inhibiting PI3K/Akt/mTOR Pathway;Oxidative Medicine and Cellular Longevity;2022-12-27

5. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment;Biochemical Pharmacology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3